Results for
""Infliximab""[mesh_terms]

The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder.

Hartej Gill, Nelson B Rodrigues, Rodrigo B Mansur, CéAnn A Marks, Joshua D DiVincenzo, Felicia Ceban, Joshua D Rosenblat, Bing Cao, Jonathan M Lieberman, Roger Ho, Roger S McIntyre

Journal of affective disorders 2022;316():273-279

Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.

Christopher Ma, John K MacDonald, Tran M Nguyen, Niels Vande Casteele, Bryan Linggi, Pavine Lefevre, Yinghong Wang, Brian G Feagan, Vipul Jairath

Digestive diseases and sciences 2022;67(4):1128-1155

A random forest model predicts responses to infliximab in Crohn's disease based on clinical and serological parameters.

Yong Li, Jianfeng Pan, Nan Zhou, Dongni Fu, Guanghui Lian, Jun Yi, Yu Peng, Xiaowei Liu

Scandinavian journal of gastroenterology 2021;56(9):1030-1039

Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab.

Yan Felix Karl Dyck, Daniel Rehm, Karsten Winkler, Volker Sandig, Wolfgang Jabs, Maria Kristina Parr

Journal of pharmaceutical and biomedical analysis 2023;235():115596

Update on biosimilars in inflammatory bowel disease: Position and recommendations in Mexico.

A Mayoral-Zavala, A Esquivel-Aguilar, C M Del Real-Calzada, Y Gutiérrez-Grobe, J Ramos-García, J L Rocha-Ramírez, M F Rojas-Illanes, B Rubio-Martínez, X Sánchez-Chávez, J K Yamamoto-Furusho

Revista de gastroenterologia de Mexico (English) 2019;83(4):414-423

Update of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population.

F Juliao-Baños, C F Grillo-Ardila, I Alfaro, M T Andara-Ramírez, O Avelar-Escobar, J Barahona-Garrido, S Bautista-Martínez, F J Bosques-Padilla, J A De Paula, K Ernest-Suárez, M T Galiano, B Iade-Vergara, M L Jara-Alba, P G Kotze, M C Miranda-Ojeda, R Ortuño-Escalante, G Otoya-Moreno, F N Piñol-Jiménez, I C Ramos-Polo, A Sambuelli, M Toro, E A Torres, G R Veitia-Velásquez, J K Yamamoto-Furusho, C Zaltman, F Steinwurz, M Vallejo-Ortega, J I Torres-Castillo, C Hamon-Pinilla, C H Calderon-Franco, A M Escobar-Villegas

Revista de gastroenterologia de Mexico (English) 2022;87(3):342-361

Immune Checkpoint Inhibitors-Induced Colitis.

Yun Tian, Hamzah Abu-Sbeih, Yinghong Wang

Advances in experimental medicine and biology 2019;995():151-157

A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar.

Walter Reinisch, Stanley Cohen, Monica Ramchandani, Majed Khraishi, Jennifer Liu, Vincent Chow, Janet Franklin, Jean-Frederic Colombel

Advances in therapy 2022;39(1):44-57

An observational study of the effects of ω-3 polyunsaturated fatty acid-supplemented parenteral nutrition on postoperative complications in patients with Crohn's disease.

Yu Shen, Huaying Liu, Weilin Qi, Wei Liu, Lingna Ye, Qian Cao, Xiaolong Ge, Wei Zhou

Annals of palliative medicine 2023;12(2):336-345

High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial.

Mitsuro Chiba, Tsuyotoshi Tsuji, Kunio Nakane, Satoko Tsuda, Hajime Ishii, Hideo Ohno, Yu Obara, Masafumi Komatsu, Haruhiko Tozawa

The Permanente journal 2021;24():1-10

Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease.

Shiva T Radhakrishnan, James L Alexander, Benjamin H Mullish, Kate I Gallagher, Nick Powell, Lucy C Hicks, Ailsa L Hart, Jia V Li, Julian R Marchesi, Horace R T Williams

Alimentary pharmacology & therapeutics 2022;55(1):26-48

Biologics in the treatment of calcium pyrophosphate deposition disease: a systematic literature review.

Edoardo Cipolletta, Andrea Di Matteo, Anna Scanu, Martina Isidori, Jacopo Di Battista, Leonardo Punzi, Walter Grassi, Emilio Filippucci

Clinical and experimental rheumatology 2020;38(5):1001-1007

Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.

Yannick Allanore, André Kahan, Jeremie Sellam, Ohvanesse G Ekindjian, Didier Borderie

Clinica chimica acta; international journal of clinical chemistry 2006;365(1-2):143-8

Treatment Patterns in Newly Diagnosed Patients with Crohn's Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan.

Fumihito Hirai, Akihito Uda, Mihoko Ota, Yukiko Takemura, Keisuke Tanaka, Ryuichi Iwakiri

Digestion 2023;104(2):109-120